Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Monthly Oral Ibandronate in Osteoporosis
NCT00148915Phase 4Completed
- Sponsor
- Roche
- Start
- Aug 2005
- Primary completion
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in osteoporosis comparing Ibandronate with Placebo (2 arms). Primary endpoint: Mean percent change in integral hip bone mineral density at 1 year. Started Aug 2005; status: completed.
02
Drugs
ibandronate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00148915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00148915.